While it is recognized that quality of life is ultimately as important as quantity of life, efforts to
implement quality of life measurement often fail. Two basic reasons for that failure include: 1) …

Efforts have recently been mounted to introduce subjective or" quality of life" parameters as
an integral part of the evaluation process in clinical cancer research. While there is no …

Often, new treatments for cancer are evaluated solely on the basis of increased survival,
depriving us of valuable information about other benefits and drawbacks of these treatments …

Over the past 20 years, changes within medicine and Society have encouraged an
expansion in conceptualizing and evaluating the goals and important outcomes of medical …

A number of single measures of quality of life have been developed over the last few years.
Some of these instruments have been used more frequently than others. Psychometric …

Although quality of life assessments have been employed successfully in descriptive and
evaluative studies in oncology, their use in cancer clinical trials has, to date, been limited. A …

Over the past 30 years, quality of life has evolved into a respected construct for evaluating
the effectiveness of treatment in health care. The field has grown in methodological rigor and …

The diagnosis and management of cancer can have a major impact on every aspect of a
patient's quality of life. Despite its importance, quality of life is rarely a reported outcome in …

There is a growing recognition in oncology of the importance of maintaining or improving
patients' quality of life (QOL) throughout the disease course. With this goal in mind, many …

New treatments for cancer often are evaluated solely on the basis of increased survival, and
thus, lack valuable information about other benefits and drawbacks of these treatments. It is …